vs

Side-by-side financial comparison of BANK OF HAWAII CORP (BOH) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

BANK OF HAWAII CORP is the larger business by last-quarter revenue ($192.3M vs $186.7M, roughly 1.0× NEOGENOMICS INC). BANK OF HAWAII CORP runs the higher net margin — 29.9% vs -57.9%, a 87.7% gap on every dollar of revenue. Over the past eight quarters, BANK OF HAWAII CORP's revenue compounded faster (10.7% CAGR vs 6.5%).

The Bank of Hawaii Corporation is an American regional commercial bank headquartered in Honolulu, Hawaii. It is Hawaii's second oldest bank and its largest locally owned bank in that the majority of the voting stockholders reside within the state. Bank of Hawaii has the most accounts, customers, branches, and ATMs of any financial institution in the state. The bank consists of four business segments: retail banking, commercial banking, investment services, and treasury. The bank is currently ...

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

BOH vs NEO — Head-to-Head

Bigger by revenue
BOH
BOH
1.0× larger
BOH
$192.3M
$186.7M
NEO
Higher net margin
BOH
BOH
87.7% more per $
BOH
29.9%
-57.9%
NEO
Faster 2-yr revenue CAGR
BOH
BOH
Annualised
BOH
10.7%
6.5%
NEO

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BOH
BOH
NEO
NEO
Revenue
$192.3M
$186.7M
Net Profit
$57.4M
$-108.0M
Gross Margin
43.3%
Operating Margin
Net Margin
29.9%
-57.9%
Revenue YoY
11.1%
Net Profit YoY
30.6%
42.0%
EPS (diluted)
$1.30
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOH
BOH
NEO
NEO
Q1 26
$192.3M
$186.7M
Q4 25
$189.6M
$190.2M
Q3 25
$182.6M
$187.8M
Q2 25
$174.5M
$181.3M
Q1 25
$169.9M
$168.0M
Q4 24
$163.2M
$172.0M
Q3 24
$162.7M
$167.8M
Q2 24
$156.9M
$164.5M
Net Profit
BOH
BOH
NEO
NEO
Q1 26
$57.4M
$-108.0M
Q4 25
$60.9M
Q3 25
$53.3M
$-27.1M
Q2 25
$47.6M
$-45.1M
Q1 25
$44.0M
$-25.9M
Q4 24
$39.2M
Q3 24
$40.4M
$-17.7M
Q2 24
$34.1M
$-18.6M
Gross Margin
BOH
BOH
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
BOH
BOH
NEO
NEO
Q1 26
Q4 25
40.9%
-7.1%
Q3 25
37.1%
-14.4%
Q2 25
34.6%
-26.3%
Q1 25
33.1%
-16.6%
Q4 24
31.6%
-10.7%
Q3 24
32.3%
-12.6%
Q2 24
28.9%
-13.3%
Net Margin
BOH
BOH
NEO
NEO
Q1 26
29.9%
-57.9%
Q4 25
32.1%
Q3 25
29.2%
-14.4%
Q2 25
27.3%
-24.9%
Q1 25
25.9%
-15.4%
Q4 24
24.0%
Q3 24
24.8%
-10.5%
Q2 24
21.7%
-11.3%
EPS (diluted)
BOH
BOH
NEO
NEO
Q1 26
$1.30
$-0.13
Q4 25
$1.40
Q3 25
$1.20
Q2 25
$1.06
Q1 25
$0.97
Q4 24
$0.85
Q3 24
$0.93
Q2 24
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOH
BOH
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$3.3M
$146.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.9B
$828.8M
Total Assets
$23.9B
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOH
BOH
NEO
NEO
Q1 26
$3.3M
$146.1M
Q4 25
$946.5M
$159.6M
Q3 25
$164.1M
Q2 25
$154.7M
Q1 25
$935.2M
$346.2M
Q4 24
$763.6M
$367.0M
Q3 24
$1.3B
$362.0M
Q2 24
$925.3M
$355.1M
Total Debt
BOH
BOH
NEO
NEO
Q1 26
Q4 25
$558.2M
$341.9M
Q3 25
$558.2M
Q2 25
$558.2M
Q1 25
$558.3M
Q4 24
$558.3M
$541.1M
Q3 24
$558.3M
Q2 24
$560.1M
Stockholders' Equity
BOH
BOH
NEO
NEO
Q1 26
$1.9B
$828.8M
Q4 25
$1.9B
$836.6M
Q3 25
$1.8B
$838.3M
Q2 25
$1.7B
$854.0M
Q1 25
$1.7B
$888.3M
Q4 24
$1.7B
$902.3M
Q3 24
$1.7B
$908.2M
Q2 24
$1.6B
$915.9M
Total Assets
BOH
BOH
NEO
NEO
Q1 26
$23.9B
$1.3B
Q4 25
$24.2B
$1.4B
Q3 25
$24.0B
$1.4B
Q2 25
$23.7B
$1.4B
Q1 25
$23.9B
$1.6B
Q4 24
$23.6B
$1.6B
Q3 24
$23.8B
$1.6B
Q2 24
$23.3B
$1.6B
Debt / Equity
BOH
BOH
NEO
NEO
Q1 26
Q4 25
0.30×
0.41×
Q3 25
0.31×
Q2 25
0.32×
Q1 25
0.33×
Q4 24
0.33×
0.60×
Q3 24
0.34×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOH
BOH
NEO
NEO
Operating Cash FlowLast quarter
$-8.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOH
BOH
NEO
NEO
Q1 26
$-8.1M
Q4 25
$218.3M
$1.3M
Q3 25
$38.5M
$8.9M
Q2 25
$81.7M
$20.3M
Q1 25
$18.3M
$-25.3M
Q4 24
$170.9M
$9.8M
Q3 24
$-20.3M
$9.2M
Q2 24
$45.7M
$13.9M
Free Cash Flow
BOH
BOH
NEO
NEO
Q1 26
Q4 25
$184.3M
$-6.5M
Q3 25
$29.8M
$570.0K
Q2 25
$72.6M
$14.0M
Q1 25
$10.2M
$-29.8M
Q4 24
$161.3M
$-1.8M
Q3 24
$-25.0M
$-1.6M
Q2 24
$40.7M
$814.0K
FCF Margin
BOH
BOH
NEO
NEO
Q1 26
Q4 25
97.2%
-3.4%
Q3 25
16.3%
0.3%
Q2 25
41.6%
7.7%
Q1 25
6.0%
-17.8%
Q4 24
98.8%
-1.0%
Q3 24
-15.3%
-0.9%
Q2 24
26.0%
0.5%
Capex Intensity
BOH
BOH
NEO
NEO
Q1 26
Q4 25
18.0%
4.1%
Q3 25
4.7%
4.4%
Q2 25
5.2%
3.5%
Q1 25
4.8%
2.7%
Q4 24
5.9%
6.7%
Q3 24
2.8%
6.4%
Q2 24
3.2%
8.0%
Cash Conversion
BOH
BOH
NEO
NEO
Q1 26
Q4 25
3.58×
Q3 25
0.72×
Q2 25
1.71×
Q1 25
0.42×
Q4 24
4.36×
Q3 24
-0.50×
Q2 24
1.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BOH
BOH

Net Interest Income$151.0M79%
Noninterest Income$41.3M21%

NEO
NEO

Segment breakdown not available.

Related Comparisons